EA
ASMB icon

Emerald Advisers’s Assembly Biosciences ASMB Stock Holding History

Emerald Advisers’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-26,475
Closed -$5.22M – 290
2020
Q3 		$5.22M Sell
26,475
-10,362
-28% -$2.61M 0.21% 109
2020
Q2 		$10.3M Buy
36,837
+402
+1% +$93.8K 0.45% 83
2020
Q1 		$6.48M Buy
36,435
+120
+0.3% +$25.7K 0.38% 92
2019
Q4 		$8.92M Sell
36,315
-86
-0.2% -$15.8K 0.38% 97
2019
Q3 		$4.29M Sell
36,401
-2,134
-6% -$323K 0.2% 112
2019
Q2 		$6.24M Sell
38,535
-497
-1% -$94.5K 0.25% 107
2019
Q1 		$9.22M Buy
39,032
+6,587
+20% +$1.67M 0.38% 99
2018
Q4 		$8.81M Sell
32,445
-583
-2% -$169K 0.43% 83
2018
Q3 		$14.7M Buy
33,028
+13,579
+70% +$6.36M 0.54% 86
2018
Q2 		$9.15M Buy
19,449
+8,796
+83% +$4.65M 0.35% 108
2018
Q1 		$6.28M Sell
10,653
-5,319
-33% -$3.3M 0.25% 114
2017
Q4 		$8.67M Buy
+15,972
New +$7.23M 0.33% 109

Other funds holding ASMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Emerald Advisers's ASMB Position: Q4 2020 in Review

Emerald Advisers sold out of Assembly Biosciences (ASMB) in Q4 2020, closing a stake of 26,475 shares — an estimated $5.22M sold.

Emerald Advisers first reported a position in ASMB in Q4 2017 and held it in 12 quarters. The position peaked at $14.7M in Q3 2018. 109 funds tracked by Wall St. Rank hold ASMB as of Q4 2020.

  • Emerald Advisers reported no remaining Assembly Biosciences position as of Q4 2020 after selling out during the quarter.
  • Emerald Advisers sold 26,475 Assembly Biosciences shares in Q4 2020, an estimated $5.22M.
  • Emerald Advisers first reported a position in Assembly Biosciences in Q4 2017 and held it in 12 quarters.
  • Emerald Advisers's Assembly Biosciences position peaked at $14.7M in Q3 2018.
  • 109 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2020.

Based on Emerald Advisers's 13F filing for Q4 2020, filed 29 Jan 2021.